Published in Am J Psychiatry on October 01, 2001
Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement. Thyroid (2014) 2.77
Diagnosis and management of depression in primary care: a clinical update and review. CMAJ (2002) 1.64
Strategies to enhance the therapeutic efficacy of antidepressants: targeting residual symptoms. Expert Rev Neurother (2009) 0.93
Mechanisms of antidepressant resistance. Front Pharmacol (2013) 0.92
The Link between Thyroid Function and Depression. J Thyroid Res (2011) 0.92
Hypothyroidism and depression. Eur Thyroid J (2013) 0.90
Pathophysiology of depression and mechanisms of treatment. Dialogues Clin Neurosci (2002) 0.84
Pharmacologic approaches to treatment resistant depression: a re-examination for the modern era. Expert Opin Pharmacother (2010) 0.84
Revisiting thyroid hormones in schizophrenia. J Thyroid Res (2012) 0.83
General and comparative efficacy and effectiveness of antidepressants in the acute treatment of depressive disorders: a report by the WPA section of pharmacopsychiatry. Eur Arch Psychiatry Clin Neurosci (2011) 0.82
What to do if an initial antidepressant fails? Can Fam Physician (2003) 0.80
Current perspectives in the management of treatment-resistant depression. Dialogues Clin Neurosci (2004) 0.78
Thyroid hormones and antidepressant response. Am J Psychiatry (2002) 0.77
Combination/augmentation strategies for improving the treatment of depression. Neuropsychiatr Dis Treat (2005) 0.77
The combination of triiodothyronine (T3) and sertraline is not superior to sertraline monotherapy in the treatment of major depressive disorder. J Psychiatr Res (2012) 0.76
The biopsychosocial model and hypothyroidism. Chiropr Osteopat (2005) 0.76
Challenging Treatment-Resistant Major Depressive Disorder: A Roadmap for Improved Therapeutics. Curr Neuropharmacol (2015) 0.76
Genome-wide linkage on chromosome 10q26 for a dimensional scale of major depression. J Affect Disord (2015) 0.76
Neural correlates of free T3 alteration after catecholamine depletion in subjects with remitted major depressive disorder and in controls. Psychopharmacology (Berl) (2013) 0.76
Relationship between the LHPP Gene Polymorphism and Resting-State Brain Activity in Major Depressive Disorder. Neural Plast (2016) 0.75
Advances in the Management of Treatment-Resistant Depression. Focus (Am Psychiatr Publ) (2010) 0.75
Baseline thyroid indices and the subsequent response to citalopram treatment, a pilot study. Brain Behav (2013) 0.75
Effect of triiodothyronine (T(3)) augmentation of acute milnacipran administration on monoamine levels: an in vivo microdialysis study in rats. Neuropsychiatr Dis Treat (2012) 0.75
The Historical Development of Immunoendocrine Concepts of Psychiatric Disorders and Their Therapy. Int J Mol Sci (2015) 0.75
Progress in the battle with the black dog: advances in the treatment of depression. Am J Psychiatry (2001) 0.75
Liothyronine for Depression: A Review and Guidance for Safety Monitoring. Innov Clin Neurosci (2017) 0.75
Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"? Schizophr Bull (2000) 9.62
WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update. Eur Respir J (2011) 8.96
Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. N Engl J Med (1985) 8.45
Deficient T cell fate specification in mice with an induced inactivation of Notch1. Immunity (1999) 8.33
Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med (1997) 7.42
Prevalence of Helicobacter pylori infection and histologic gastritis in asymptomatic persons. N Engl J Med (1989) 5.78
Detection and in situ identification of representatives of a widely distributed new bacterial phylum. FEMS Microbiol Lett (1997) 5.20
Disability income, cocaine use, and repeated hospitalization among schizophrenic cocaine abusers--a government-sponsored revolving door? N Engl J Med (1995) 4.77
Skills training versus psychosocial occupational therapy for persons with persistent schizophrenia. Am J Psychiatry (1998) 4.31
Complete genome sequence of the marine planctomycete Pirellula sp. strain 1. Proc Natl Acad Sci U S A (2003) 4.16
Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update. Cancer (1983) 3.94
Informed consent: assessment of comprehension. Am J Psychiatry (1998) 3.74
Training and quality assurance with the Structured Clinical Interview for DSM-IV (SCID-I/P). Psychiatry Res (1998) 3.69
Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med (1985) 3.41
Epidemiology of vertebral fractures in women. Am J Epidemiol (1989) 3.27
The National Depressive and Manic-depressive Association (DMDA) survey of bipolar members. J Affect Disord (1994) 3.15
The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breast. Surg Gynecol Obstet (1981) 3.11
ErbB3 is required for normal cerebellar and cardiac development: a comparison with ErbB2-and heregulin-deficient mice. Development (1997) 3.04
Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response. Mol Psychiatry (2004) 2.98
Age-related changes in frontal and temporal lobe volumes in men: a magnetic resonance imaging study. Arch Gen Psychiatry (2001) 2.91
Tranylcypromine vs. lamotrigine in the treatment of refractory bipolar depression: a failed but clinically useful study. Acta Psychiatr Scand (2007) 2.89
The genome of Desulfotalea psychrophila, a sulfate-reducing bacterium from permanently cold Arctic sediments. Environ Microbiol (2004) 2.66
Idiopathic eosinophilic esophagitis is associated with a T(H)2-type allergic inflammatory response. J Allergy Clin Immunol (2001) 2.62
The orphan receptor CRF2-4 is an essential subunit of the interleukin 10 receptor. J Exp Med (1998) 2.55
Implications of therapist effects for the design and analysis of comparative studies of psychotherapies. J Consult Clin Psychol (1991) 2.49
Clinical outcome following neuroleptic discontinuation in patients with remitted recent-onset schizophrenia. Am J Psychiatry (2001) 2.47
Soluble TNF-alpha receptor 1 and IL-6 plasma levels in humans subjected to the sleep deprivation model of spaceflight. J Allergy Clin Immunol (2001) 2.46
The Stanley Foundation Bipolar Treatment Outcome Network. II. Demographics and illness characteristics of the first 261 patients. J Affect Disord (2001) 2.43
Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder. Am J Psychiatry (2001) 2.38
Sleep loss reduces diurnal rhythm amplitude of leptin in healthy men. J Neuroendocrinol (2003) 2.35
Lysophosphatidic acid mediates the rapid activation of platelets and endothelial cells by mildly oxidized low density lipoprotein and accumulates in human atherosclerotic lesions. Proc Natl Acad Sci U S A (1999) 2.33
Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder. Arch Gen Psychiatry (1992) 2.31
Syncope: a videometric analysis of 56 episodes of transient cerebral hypoxia. Ann Neurol (1994) 2.19
Independent assessment of manic and depressive symptoms by self-rating. Scale characteristics and implications for the study of mania. Arch Gen Psychiatry (1991) 2.18
Evidence of chaotic mood variation in bipolar disorder. Arch Gen Psychiatry (1995) 2.15
Pharmacologic management of psychiatric illness during pregnancy: dilemmas and guidelines. Am J Psychiatry (1996) 2.14
Transfer of airway skills from manikin training to patient: success of ventilation with facemask or LMA-Supreme(TM) by medical students. Anaesthesia (2013) 2.09
Developmental Processes in Schizophrenic Disorders: longitudinal studies of vulnerability and stress. Schizophr Bull (1992) 2.08
Mutations in the gene encoding epsilon-sarcoglycan cause myoclonus-dystonia syndrome. Nat Genet (2001) 2.06
Neoadjuvant therapy of esophageal squamous cell carcinoma: response evaluation by positron emission tomography. Ann Surg (2001) 2.04
Early mycological treatment failure in AIDS-associated cryptococcal meningitis. Clin Infect Dis (1999) 2.04
[Monitoring of liver function in the critically ill]. Anaesthesist (2014) 1.99
Fluconazole combined with flucytosine for treatment of cryptococcal meningitis in patients with AIDS. Clin Infect Dis (1994) 1.99
Transgenic knockouts reveal a critical requirement for pancreatic beta cell glucokinase in maintaining glucose homeostasis. Cell (1995) 1.99
Funding Canada's health care system: a tax-based alternative to privatization. CMAJ (1998) 1.92
Maternal and newborn vitamin D status and its impact on food allergy development in the German LINA cohort study. Allergy (2012) 1.88
[Generation Y : recruitment, retention and development]. Anaesthesist (2011) 1.86
Transcriptomic and proteomic patterns of systemic inflammation in on-pump and off-pump coronary artery bypass grafting. Circulation (2005) 1.83
CpG-containing synthetic oligonucleotides promote B and cytotoxic T cell responses to protein antigen: a new class of vaccine adjuvants. Eur J Immunol (1997) 1.79
Growth rate of 147 mammary carcinomas. Cancer (1980) 1.62
Absence of evidence for bornavirus infection in schizophrenia, bipolar disorder and major depressive disorder. Mol Psychiatry (2012) 1.59
Does prophylaxis-delay in bipolar disorder influence outcome? Results from a long-term study of 147 patients. Acta Psychiatr Scand (2003) 1.58
Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline. Br J Psychiatry (2006) 1.58
X-ray structure of clotting factor IXa: active site and module structure related to Xase activity and hemophilia B. Proc Natl Acad Sci U S A (1995) 1.58
Family factors and the course of bipolar affective disorder. Arch Gen Psychiatry (1988) 1.57
Immunostimulatory DNA: sequence-dependent production of potentially harmful or useful cytokines. Eur J Immunol (1997) 1.56
Cerebral and extracerebral release of protein S100B in cardiac surgical patients. Anaesthesia (2004) 1.55
Patients' perceptions of family emotional climate and outcome in schizophrenia. Br J Psychiatry (1993) 1.55
Common variants in FCER1A influence total serum IgE levels from cord blood up to six years of life. Allergy (2009) 1.54
Amygdala enlargement in bipolar disorder and hippocampal reduction in schizophrenia: an MRI study demonstrating neuroanatomic specificity. Arch Gen Psychiatry (1998) 1.53
Differential expression pattern of heme oxygenase-1/heat shock protein 32 and nitric oxide synthase-II and their impact on liver injury in a rat model of hemorrhage and resuscitation. Crit Care Med (1999) 1.53
Hepatitis C and liver fibrosis. Cell Death Differ (2003) 1.53
Novel antipsychotics: comparison of weight gain liabilities. J Clin Psychiatry (1999) 1.53
An MRI study of temporal lobe structures in men with bipolar disorder or schizophrenia. Biol Psychiatry (2000) 1.53
Neuropsychological testing of cognitive impairment in euthymic bipolar disorder: an individual patient data meta-analysis. Acta Psychiatr Scand (2013) 1.52
Mass fainting at rock concerts. N Engl J Med (1995) 1.51
Syncope and near-death experience. Lancet (1994) 1.50
A hypothesis of thyroid-catecholamine-receptor interaction. Its relevance to affective illness. Arch Gen Psychiatry (1981) 1.49
Differential efficacy of olanzapine for deficit and nondeficit negative symptoms in schizophrenia. Am J Psychiatry (2000) 1.49
Mixed agonistic-antagonistic cytokine response in whole blood from patients undergoing abdominal aortic aneurysm repair. Intensive Care Med (1999) 1.49
Mood and body weight in a woman with rapid cycling bipolar disorder: a case report. Psychosom Med (1993) 1.48
Effect of severity of meningitis on fungicidal activity of flucytosine combined with fluconazole in a murine model of cryptococcal meningitis. Antimicrob Agents Chemother (1997) 1.46
Effects of mood and subtype on cerebral glucose metabolism in treatment-resistant bipolar disorder. Biol Psychiatry (2001) 1.46
Nimodipine monotherapy and carbamazepine augmentation in patients with refractory recurrent affective illness. J Clin Psychopharmacol (1998) 1.46
Skinfold thickness measurements in obese subjects. Am J Clin Nutr (1990) 1.45
Two heads are better than one: crystal structure of the insect derived double domain Kazal inhibitor rhodniin in complex with thrombin. EMBO J (1995) 1.45
Myoclonus in patients treated with clozapine: a case series. J Clin Psychiatry (1995) 1.45
Mildly oxidized low density lipoprotein induces contraction of human endothelial cells through activation of Rho/Rho kinase and inhibition of myosin light chain phosphatase. J Biol Chem (1999) 1.45
Backward masking in schizophrenia and mania. II. Specifying the visual channels. Arch Gen Psychiatry (1994) 1.44
Dynamics of viral variants in HIV-1 Nef and specific cytotoxic T lymphocytes in vivo. J Immunol (1996) 1.43
The thyroid-brain interaction in thyroid disorders and mood disorders. J Neuroendocrinol (2008) 1.43
Staphylococcal alpha-toxin elicits hypertension in isolated rabbit lungs. Evidence for thromboxane formation and the role of extracellular calcium. J Clin Invest (1984) 1.43
Bispectral index-controlled anaesthesia for electroconvulsive therapy. Eur J Anaesthesiol (2006) 1.43
Sequence constraints and recognition by CTL of an HLA-B27-restricted HIV-1 gag epitope. J Immunol (1995) 1.42
Plasma levels of fluphenazine in patients receiving fluphenazine decanoate. Relationship to clinical response. Br J Psychiatry (1991) 1.42
In vivo evaluation of brain iron in Alzheimer disease using magnetic resonance imaging. Arch Gen Psychiatry (2000) 1.41
Lithium clinics: theory and practice. Hosp Community Psychiatry (1984) 1.41
Effect of fluconazole on fungicidal activity of flucytosine in murine cryptococcal meningitis. Antimicrob Agents Chemother (1996) 1.41
The temporal relationship between depressive and psychotic symptoms in recent-onset schizophrenia. Am J Psychiatry (1990) 1.40
Backward masking in schizophrenia and mania. I. Specifying a mechanism. Arch Gen Psychiatry (1994) 1.40
[Lithium in the treatment of acute depression]. Fortschr Neurol Psychiatr (1998) 1.40
The relationship between antimanic agent for treatment of classic or dysphoric mania and length of hospital stay. J Clin Psychiatry (1996) 1.40
Time experience and time judgment in major depression, mania and healthy subjects. A controlled study of 93 subjects. Acta Psychiatr Scand (2004) 1.40
[Comparison of premedication regimes. A randomized, controlled trial]. Anaesthesist (2007) 1.39
[Extravasal position of central venous catheters despite unsuspicious ECG-guidance]. Anasthesiol Intensivmed Notfallmed Schmerzther (2005) 1.39